GenFleet Therapeutics (Shanghai) (HKG:2595) is proposing to buy back up to HK$350 million Hong Kong-listed shares, according to a Monday Hong Kong bourse filing.
The biopharmaceutical company will repurchase the shares from the open market from time to time.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments